Bilanafos

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596769

CAS#: 35597-43-4

Description: Bilanafos is an Anti-Bacterial Agent.

Chemical Structure

img
Bilanafos
CAS# 35597-43-4
Instruction

Theoretical Analysis

MedKoo Cat#: 596769
Name: Bilanafos
CAS#: 35597-43-4
Chemical Formula: C11H22N3O6P
Exact Mass: 323.12
Molecular Weight: 323.280
Elemental Analysis: C, 40.87; H, 6.86; N, 13.00; O, 29.69; P, 9.58

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Bilanafos; Bialaphos; Herby; Antibiotic SF 1293;

IUPAC/Chemical Name: (2-amino-4-((hydroxymethyl)hydrophosphoryl)butanoyl)-L-alanyl-L-alanine

InChi Key: VGEZOZJJXPKDEJ-WPZUCAASSA-N

InChi Code: InChI=1S/C11H22N3O6P/c1-6(9(16)14-7(2)11(18)19)13-10(17)8(12)3-4-21(20)5-15/h6-8,15,21H,3-5,12H2,1-2H3,(H,13,17)(H,14,16)(H,18,19)/t6-,7-,8?/m0/s1

SMILES Code: C[C@@H](C(O)=O)NC([C@H](C)NC(C(N)CCP(CO)=O)=O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 323.28 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Bilanakis N, Vratsista A, Siorou S. A brain ependymoma with psychiatric manifestation. J BUON. 2017 Nov-Dec;22(6):1604-1605. PubMed PMID: 29332363.

2: Bilanakis N, Peritogiannis VK, Vratsista A. Treatment decision-making capacity in hospitalized patients with schizophrenia. Psychiatriki. 2017 Jan-Mar;28(1):37-45. doi: 10.22365/jpsych.2017.281.37. PubMed PMID: 28541237.

3: Hargarter L, Bergmans P, Cherubin P, Keim S, Conca A, Serrano-Blanco A, Bitter I, Bilanakis N, Schreiner A. Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia. Expert Opin Pharmacother. 2016 Jun;17(8):1043-53. doi: 10.1080/14656566.2016.1174692. Epub 2016 May 9. PubMed PMID: 27042990; PubMed Central PMCID: PMC4898156.

4: Bilanakis N, Vratsista A, Athanasiou E, Niakas D, Peritogiannis V. Medical patients' treatment decision making capacity: a report from a general hospital in Greece. Clin Pract Epidemiol Ment Health. 2014 Nov 26;10:133-9. doi: 10.2174/1745017901410010133. eCollection 2014. PubMed PMID: 25505489; PubMed Central PMCID: PMC4260233.

5: Bilanakis N, Vratsista A, Kalampokis G, Papamichael G, Peritogiannis V. The Greek version of the MacArthur competence assessment tool for treatment: reliability and validity. Evaluation of capacity for treatment decisions in Greek psychiatric patients. Ann Gen Psychiatry. 2013 Apr 9;12(1):10. doi: 10.1186/1744-859X-12-10. PubMed PMID: 23570333; PubMed Central PMCID: PMC3648422.

6: Bilanakis N. [Compulsory hospitalization: α case of conflict between the psychiatrist and the persecutor due to the obscurity of the law]. Psychiatriki. 2012 Jul-Sep;23(3):255-61. Greek, Modern. PubMed PMID: 23073548.

7: Bilanakis N, Papamichael G, Peritogiannis V. Chemical restraint in routine clinical practice: a report from a general hospital psychiatric ward in Greece. Ann Gen Psychiatry. 2011 Feb 24;10:4. doi: 10.1186/1744-859X-10-4. PubMed PMID: 21349171; PubMed Central PMCID: PMC3050779.

8: Bilanakis N, Kalampokis G, Christou K, Peritogiannis V. Use of coercive physical measures in a psychiatric ward of a general hospital in Greece. Int J Soc Psychiatry. 2010 Jul;56(4):402-11. doi: 10.1177/0020764009106620. Epub 2009 Jul 23. PubMed PMID: 19628555.

9: Bilanakis N, Peritogiannis V. Attitudes of patients and families toward restraint and seclusion. Psychiatr Serv. 2008 Oct;59(10):1220. doi: 10.1176/appi.ps.59.10.1220. PubMed PMID: 18832516.

10: Bilanakis N, Peritogiannis V, Kalampokis G. Infections as complications of neuroleptic malignant syndrome. World J Biol Psychiatry. 2009;10(4 Pt 3):973-6. doi: 10.1080/15622970801935578. PubMed PMID: 18609425.

11: Geitona M, Ollandezos M, Kousoulakou C, Agelopoulos E, Zaharakis K, Kakavas P, Karpouza B, Kesidou S, Bilanakis N, Papamichael E, Papanicolaou S, Chaidemenos A, Chamogeorgakis T, Kyriopoulos J. [The cost of treating schizophrenia in Greece]. Psychiatriki. 2007 Jan;18(1):47-58. Greek, Modern. PubMed PMID: 22466429.

12: Bilanakis N. Psychogenic urinary retention. Gen Hosp Psychiatry. 2006 May-Jun;28(3):259-61. PubMed PMID: 16675372.

13: Bilanakis N, Gibiriti M. Lithium intoxication, hypercalcemia and "accidentally" induced food and water aversion: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):201-3. PubMed PMID: 14687875.

14: Bilanakis N, Madianos MG, Liakos A. Psychiatric morbidity among repatriated Greek migrants in a rural area. Eur Arch Psychiatry Clin Neurosci. 1995;245(1):36-44. PubMed PMID: 7786910.